Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taron

Showing results (271-280 of 327) with videos related to

Pageof 33
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 28, 2010
Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshopRobert Pirker, Felix J F Herth, Keith M Kerr, et al.
NPJ Digital Medicine|March 6, 2021
Deep-learning system to improve the quality and efficiency of volumetric heart segmentation for breast cancerRoman Zeleznik, Jakob Weiss, Jana Taron, et al.
Human Genetics|August 1, 1996
Fetal cells in maternal blood: recovery by charge flow separationS S Wachtel, D Sammons, M Manley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 6, 2012
Randomized, phase III study of gemcitabine or erlotinib maintenance therapy versus observation, with predefined second-line treatment, after cisplatin-gemcitabine induction chemotherapy in advanced non-small-cell lung cancerMaurice Pérol, Christos Chouaid, David Pérol, et al.
Lung Cancer (Amsterdam, Netherlands)|September 8, 2009
Blood-based CHRNA3 single nucleotide polymorphism and outcome in advanced non-small-cell lung cancer patientsEnric Carcereny, Jose Luis Ramirez, Maria Sanchez-Ronco, et al.
Cancer Treatment Reviews|June 24, 2014
Novel therapeutic strategies for patients with NSCLC that do not respond to treatment with EGFR inhibitorsChristian Rolfo, Elisa Giovannetti, David S Hong, et al.
Lung Cancer (Amsterdam, Netherlands)|August 14, 2010
First-line therapy and methylation status of CHFR in serum influence outcome to chemotherapy versus EGFR tyrosine kinase inhibitors as second-line therapy in stage IV non-small-cell lung cancer patientsFernanda Salazar, Miguel Angel Molina, Maria Sanchez-Ronco, et al.
Lung Cancer (Amsterdam, Netherlands)|March 15, 2016
Aberrant gene methylation and bronchial dysplasia in high risk lung cancer patientsA Rosell, N Rodríguez, E Monsó, et al.
Oncogene|June 6, 2003
Transcripts in pretreatment biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancerRafael Rosell, Giorgio Scagliotti, Kathleen D Danenberg, et al.
European Urology|July 24, 2025
First-line Pembrolizumab Plus Lenvatinib for Advanced Non-clear-cell Renal Cell Carcinoma: Updated Results from the Phase 2 KEYNOTE-B61 TrialMartin H Voss, Howard Gurney, Vagif Atduev, et al.
Pageof 33

Showing results (271-280 of 327) with videos related to

Sort By:
Pageof 33
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 28, 2010
Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshopRobert Pirker, Felix J F Herth, Keith M Kerr, et al.
NPJ Digital Medicine|March 6, 2021
Deep-learning system to improve the quality and efficiency of volumetric heart segmentation for breast cancerRoman Zeleznik, Jakob Weiss, Jana Taron, et al.
Human Genetics|August 1, 1996
Fetal cells in maternal blood: recovery by charge flow separationS S Wachtel, D Sammons, M Manley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 6, 2012
Randomized, phase III study of gemcitabine or erlotinib maintenance therapy versus observation, with predefined second-line treatment, after cisplatin-gemcitabine induction chemotherapy in advanced non-small-cell lung cancerMaurice Pérol, Christos Chouaid, David Pérol, et al.
Lung Cancer (Amsterdam, Netherlands)|September 8, 2009
Blood-based CHRNA3 single nucleotide polymorphism and outcome in advanced non-small-cell lung cancer patientsEnric Carcereny, Jose Luis Ramirez, Maria Sanchez-Ronco, et al.
Cancer Treatment Reviews|June 24, 2014
Novel therapeutic strategies for patients with NSCLC that do not respond to treatment with EGFR inhibitorsChristian Rolfo, Elisa Giovannetti, David S Hong, et al.
Lung Cancer (Amsterdam, Netherlands)|August 14, 2010
First-line therapy and methylation status of CHFR in serum influence outcome to chemotherapy versus EGFR tyrosine kinase inhibitors as second-line therapy in stage IV non-small-cell lung cancer patientsFernanda Salazar, Miguel Angel Molina, Maria Sanchez-Ronco, et al.
Lung Cancer (Amsterdam, Netherlands)|March 15, 2016
Aberrant gene methylation and bronchial dysplasia in high risk lung cancer patientsA Rosell, N Rodríguez, E Monsó, et al.
Oncogene|June 6, 2003
Transcripts in pretreatment biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancerRafael Rosell, Giorgio Scagliotti, Kathleen D Danenberg, et al.
European Urology|July 24, 2025
First-line Pembrolizumab Plus Lenvatinib for Advanced Non-clear-cell Renal Cell Carcinoma: Updated Results from the Phase 2 KEYNOTE-B61 TrialMartin H Voss, Howard Gurney, Vagif Atduev, et al.
Pageof 33